|
Cryoprecipitate Approval Criteria
Principle
To ensure appropriate use of cryoprecipitate,
approval guidelines and criteria are established.
Purpose
This policy provides criteria for
cryoprecipitate approval.
Scope
The policy applies to the
Transfusion Service section of Laboratory Medicine.
Policy
A. Requests for cryoprecipitate
that appear excessive or unreasonable should be referred to the medical director
or resident for evaluation.
B. To avoid delay, "on hold" orders for
cryoprecipitate should be reviewed in advance of need to ensure the order meets
criteria. Approved cryoprecipitate orders are not thawed/pooled until an order
to transfuse is received.
C. Patients with the following clinical
conditions/diagnoses are approved to receive cryoprecipitate.
1. Surgical, M1W, trauma, bleeding, or
post-operative patient.
a. Patient is considered
post-operative for 24 hours.
2. Liver or heart transplant patient.
a. Patient is approved to receive
cryoprecipitate during surgery and post-operatively for the duration of the
hospital admission.
3.
Fibrinogen level < 100 mg/dL.
a. Fibrinogen
level must be performed in past 24 hours.
D. Patients not meeting cryoprecipitate
criteria are referred to the resident for evaluation.
1. Obtain the following information
prior to calling the resident:
a. Name of the
ordering MD and Simon page number.
b. Patient
location.
c. Indication(s)
for cryoprecipitate transfusion.
i. Ask the nurse taking care of the
patient what the indications are for ordering the transfusion.
2. Contact the resident
with patient and cryoprecipitate order information.
a. Clearly document resident's decision
to approve or disapprove cryoprecipitate order on request form.
Reference
N/A
| 